Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...
Hosted on MSN
Q&A: Researchers discuss a protective kidney RNA that could transform disease treatment
Guoping Li, Ph.D., of the Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital, is the lead author, and Saumya Das, MD, Ph.D., of the Cardiovascular Research ...
Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.
SGLT2 inhibitors combat inflammation and slow kidney disease by elevating S-adenosylmethionine (SAM) levels, which suppress inflammatory gene activity through epigenetic modification. The benefits of ...
"This is the first GLP-1 receptor agonists study to show significant reduction in the risk of kidney failure…Our study establishes GLP-1 receptor agonists as an important kidney-protective class of ...
Nephrologists are well aware that stimulation of the renal sympathetic nerves causes increased renin release, increased sodium reabsorption, and a reduction of renal blood flow. These elements of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results